The Flinn Foundation Seed Grants to Promote Translational Research Program opened the application for its next cycle of funding on Monday, Aug. 14, 2023. The deadline to apply is Monday, Oct. 2, 2023.
The Flinn Foundation will fund 10 research teams affiliated with an Arizona university, research institution, or health-care system that are advancing new products or services addressing significant clinical needs.
The awardees will each receive a $100,000 grant over 18 months, plus programmatic benefits. At the end of the grant period, up to two of the most successful projects may receive up to an additional $100,000 over the following year.
Each supported team will use the 18-month grant period to de-risk its product/process, refine its design, and/or acquire key validation data and stakeholder feedback—and secure, or have a well-defined plan to secure, new sources of funding to advance toward positive patient impact.
The Flinn Foundation Seed Grants to Promote Translational Research Program has aimed since its inception a decade ago to bridge the gap between Arizona’s academic researchers and clinicians and enable them to work together to bring clinically relevant products to market.
With more than 60 seed grants awarded by the Flinn Foundation, totaling about $7.5 million, these partnerships are developing a broad array of solutions in diagnostics, medical devices, therapeutics, precision medicine, and health-care delivery.
Who Should Apply
The Flinn Foundation seeks proposals from teams with innovative solutions to well-defined and compelling clinical needs in the areas of precision medicine, diagnostics, devices, therapeutics, and health-care delivery processes. Proposed projects must have reached a point where they have significant potential to turn bench results into viable products or systems impacting patients in Arizona and beyond.
This program supports teams that include both scientists and clinicians affiliated with Arizona-based research institutions and/or health-care systems. Funded projects must focus on bringing new products and services to benefit patients.
For more information about the application process, email Mary O’Reilly, Ph.D., Flinn Foundation Vice President, Bioscience Research Programs, or Wiley Larsen, Flinn Foundation Program Manager, Translational Bioscience and Entrepreneurship.